Chemoinformaics analysis of Rottlerin/mallotoxin
| Molecular Weight | 516.546 | nRot | 6 |
| Heavy Atom Molecular Weight | 488.322 | nRig | 26 |
| Exact Molecular Weight | 516.178 | nRing | 4 |
| Solubility: LogS | -3.626 | nHRing | 1 |
| Solubility: LogP | 6.15 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 66 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 3 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 30 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 18 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 18 |
| nHA | 8 | APOL | 75.1862 |
| nHD | 5 | BPOL | 31.5618 |
| QED | 0.216 |
| Synth | 3.314 |
| Natural Product Likeliness | 1.717 |
| NR-PPAR-gamma | 0.565 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.543 |
| Pgp-sub | 0.001 |
| HIA | 0.102 |
| CACO-2 | -5.622 |
| MDCK | 0.0000235 |
| BBB | 0.001 |
| PPB | 1.04869 |
| VDSS | 0.206 |
| FU | 0.00607257 |
| CYP1A2-inh | 0.201 |
| CYP1A2-sub | 0.359 |
| CYP2c19-inh | 0.332 |
| CYP2c19-sub | 0.062 |
| CYP2c9-inh | 0.833 |
| CYP2c9-sub | 0.66 |
| CYP2d6-inh | 0.284 |
| CYP2d6-sub | 0.177 |
| CYP3a4-inh | 0.176 |
| CYP3a4-sub | 0.189 |
| CL | 2.52 |
| T12 | 0.343 |
| hERG | 0.016 |
| Ames | 0.04 |
| ROA | 0.171 |
| SkinSen | 0.958 |
| Carcinogencity | 0.457 |
| EI | 0.851 |
| Respiratory | 0.474 |
| NR-Aromatase | 0.91 |
| Antiviral | Yes |
| Prediction | 0.862667 |